CT SB00142 | 2023 | General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 13 2023 - 25% progression, died in committee
Action: 2023-01-13 - Referred to Joint Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 13 2023 - 25% progression, died in committee
Action: 2023-01-13 - Referred to Joint Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To: (1) Establish a state-operated reinsurance program; (2) require the state to apply for a state innovation waiver to fund such program; (3) require the Office of Health Strategy to consider and adjust for any unintended effects or impacts of primary care spending targets on funding for those with developmental disabilities when benchmarking; (4) require the Office of Health Strategy to institute a program for prescription drug benchmarking; and (5) establish a task force to study the impact of spread pricing with prescription drugs and the savings or potential savings under current and alternative programs for the pooling of purchasing of prescription drugs.
Title
An Act Concerning A State-operated Reinsurance Program And Health Care Cost Growth.
Sponsors
Sen. Kevin Kelly [R] |
History
Date | Chamber | Action |
---|---|---|
2023-01-13 | Senate | Referred to Joint Committee on Insurance and Real Estate |
Connecticut State Sources
Type | Source |
---|---|
Summary | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00142&which_year=2023 |
Text | https://www.cga.ct.gov/2023/TOB/S/PDF/2023SB-00142-R00-SB.PDF |